Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicita Andreotti

Showing results (71-80 of 236) with videos related to

Pageof 24
Sort By:
Pharmacological Research|December 18, 2020
Methodological education in response to the quality of COVID-19 publicationsFelicita Andreotti, Cristina Gervasoni, Giuseppe Di Pasquale, et al.
Journal of the American College of Cardiology|April 11, 2020
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI TrialsMattia Galli, Felicita Andreotti, Domenico D'Amario, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 13, 2011
Polycythemia, vascular function, and hemoglobin-nitric oxide reactionsFelicita Andreotti, Teodosio Pafundi, Filippo Crea, et al.
European Heart Journal|April 1, 2005
Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery diseaseIgnatios Ikonomidis, John Lekakis, Ioanna Revela, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 19, 2020
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faithMattia Galli, Felicita Andreotti, Domenico D'Amario, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fogGiuseppe Di Pasquale, Aldo P Maggioni, Cristina Gervasoni, et al.
International Journal of Cardiology|July 2, 2020
COVID-19 trials in Italy: A call for simplicity, top standards and global poolingAldo P Maggioni, Felicita Andreotti, Cristina Gervasoni, et al.
Expert Opinion on Drug Safety|November 12, 2020
Safety and efficacy of P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionsMattia Galli, Davide Capodanno, Felicita Andreotti, et al.
European Heart Journal|September 7, 2005
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patientsFelicita Andreotti, Luca Testa, Giuseppe G L Biondi-Zoccai, et al.
Current Cardiology Reports|April 13, 2016
Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS GuidelinesMarco Roffi, Baris Gencer, Robert F Storey, et al.
Pageof 24

Showing results (71-80 of 236) with videos related to

Sort By:
Pageof 24
Pharmacological Research|December 18, 2020
Methodological education in response to the quality of COVID-19 publicationsFelicita Andreotti, Cristina Gervasoni, Giuseppe Di Pasquale, et al.
Journal of the American College of Cardiology|April 11, 2020
Stent Thrombosis With Dual Antithrombotic Therapy in Atrial Fibrillation-ACS/PCI TrialsMattia Galli, Felicita Andreotti, Domenico D'Amario, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 13, 2011
Polycythemia, vascular function, and hemoglobin-nitric oxide reactionsFelicita Andreotti, Teodosio Pafundi, Filippo Crea, et al.
European Heart Journal|April 1, 2005
Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery diseaseIgnatios Ikonomidis, John Lekakis, Ioanna Revela, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 19, 2020
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faithMattia Galli, Felicita Andreotti, Domenico D'Amario, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 29, 2020
Trials and tribulations of coronavirus disease-2019 research: with a few bright lights in the fogGiuseppe Di Pasquale, Aldo P Maggioni, Cristina Gervasoni, et al.
International Journal of Cardiology|July 2, 2020
COVID-19 trials in Italy: A call for simplicity, top standards and global poolingAldo P Maggioni, Felicita Andreotti, Cristina Gervasoni, et al.
Expert Opinion on Drug Safety|November 12, 2020
Safety and efficacy of P2Y<sub>12</sub> inhibitor monotherapy in patients undergoing percutaneous coronary interventionsMattia Galli, Davide Capodanno, Felicita Andreotti, et al.
European Heart Journal|September 7, 2005
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patientsFelicita Andreotti, Luca Testa, Giuseppe G L Biondi-Zoccai, et al.
Current Cardiology Reports|April 13, 2016
Clinical Perspectives and Pearls from the 2015 ESC NSTE-ACS GuidelinesMarco Roffi, Baris Gencer, Robert F Storey, et al.
Pageof 24